CJC-1295 (No DAC) Solubility: Diluents, Concentrations & Clouding

Direct Overview of CJC-1295 (No DAC) Solubility & Practical Concentrations

In laboratory research settings, cjc-1295 (no dac) solubility depends heavily on the chosen diluent, ionic strength, and solution pH. As a synthetic 29-amino acid peptide analog (often referred to as Modified GRF 1-29), the compound exhibits excellent solubility in aqueous solutions under mildly acidic to neutral conditions. Researchers working with high-purity CJC-1295 (No DAC) typically reconstitute the lyophilized powder to concentrations ranging between 1.0 mg/mL and 5.0 mg/mL for standard in vitro assays and analytical procedures.

The standard primary diluent for working stock solutions is Bacteriostatic Water for Injection (0.9% benzyl alcohol). At concentrations up to 2.0 mg/mL, CJC-1295 (No DAC) generally dissolves rapidly upon contact with bacteriostatic water without requiring extensive agitation. When higher stock concentrations (3.0 mg/mL to 5.0 mg/mL) are required for specialized assay setups, dissolution may proceed more slowly, occasionally requiring targeted temperature equilibration or controlled passive liquid movement.

Exceeding 5.0 mg/mL in standard aqueous diluents is generally not recommended for benchtop assays. At higher concentrations, the risk of concentration-dependent peptide aggregation, precipitation, or reversible self-association increases significantly, particularly if the pH strays near the peptide's isoelectric zone. Researchers evaluating target concentrations for experimental design should consult our interactive reconstitution calculator to determine precise volume and diluent requirements before processing lyophilized stock.

Structural Basis of CJC-1295 (No DAC) and GHRH Analog Behavior

To understand the thermodynamic and kinetic behavior of CJC-1295 (No DAC) in liquid media, researchers must examine its primary structure. CJC-1295 (No DAC) is a synthetic analog of growth hormone-releasing hormone (GHRH), modified at positions 2, 8, 15, and 27 (D-Ala2, Gln8, Ala15, Leu27) relative to native GHRH(1-29). These specific amino acid substitutions enhance metabolic stability against enzymatic cleavage, particularly by dipeptidyl peptidase-IV (DPP-IV), while preserving receptor binding affinity.

Preclinical studies suggest that CJC-1295 (No DAC) functions as a potent GHRH analog, activating the GHRH receptor signal transduction pathway to stimulate endogenous growth hormone (GH) secretion. In animal models and cell culture systems, this secretagogue activity sustains GH release and elevates downstream insulin-like growth factor 1 (IGF-1) levels, making it a key tool in tissue repair research, cellular proliferation studies, and metabolic pathway exploration.

The presence of hydrophobic residues balanced by basic and acidic side chains creates amphipathic characteristics across the alpha-helical structure. Consequently, the peptide's solvation shell relies on hydrophobic interactions and hydrogen bonding with the aqueous phase. Disruption of this shell through incorrect diluent ionic strength or mechanical shear can lead to rapid denaturation or physical drop-out from solution.

Diluent Selection Matrix: Bacteriostatic Water, Sterile Water, and PBS

Selecting the correct solvent system is critical to maintaining peptide integrity and predictable cjc-1295 (no dac) solubility over extended experimental timelines. The choice of diluent directly influences physical stability, bacterial growth suppression, and compatibility with specific assay detection methods.

1. **Bacteriostatic Water (0.9% Benzyl Alcohol):** This is the preferred medium for multi-use research vials intended for storage over multiple days or weeks at 2–8°C. The 0.9% benzyl alcohol content serves as a preservative against microbial contamination. CJC-1295 (No DAC) demonstrates robust solubility in bacteriostatic water up to 2.0–3.0 mg/mL without altered secondary structure.

2. **Sterile Water for Injection (Sterile Water):** Ideal for immediate single-use assays or sensitive cell culture setups where benzyl alcohol might induce cellular toxicity. While CJC-1295 (No DAC) dissolves easily in plain sterile water, the absence of a preservative means reconstituted solutions must be used immediately or frozen to avoid microbial proliferation.

3. **Phosphate-Buffered Saline (PBS, pH 7.4):** While PBS is standard for cell culture applications, direct reconstitution of dry lyophilized peptide into standard 1x PBS can sometimes cause localized precipitation or slow dissolution due to initial salt concentration effects. If PBS is required for downstream work, it is best practice to first dissolve the peptide in a small volume of sterile water before diluting into PBS, or to utilize a slightly acidified buffer system.

pH Sensitivity and Isoelectric Precipitation Dynamics

Like many bio-active peptides listed in our catalog of research peptides, CJC-1295 (No DAC) possesses an inherent isoelectric point (pI) dictated by its charged side-chain amino acids (lysine, arginine, aspartic acid, and glutamic acid). When the solution pH approaches the pI of the peptide, net molecular charge approaches zero, drastically reducing electrostatic repulsion between individual peptide chains.

At or near its pI, CJC-1295 (No DAC) exhibits a dramatic drop in solubility, leading to rapid self-association, opalescence, or insoluble aggregate formation. In standard bacteriostatic or sterile water, the natural pH usually ranges between 5.0 and 6.5—an environment where CJC-1295 (No DAC) carries a net positive charge, ensuring strong solvation and solution stability.

If researchers attempt to dilute CJC-1295 (No DAC) into strongly basic solutions (pH > 8.0) or high-saline buffers without prior solvation, localized pH gradients can trigger irreversible aggregation. Maintaining a mild buffer environment (pH 5.5 to 7.0) ensures optimal ionic stability for long-term experimental consistency.

Evaluating Clarity: Causes of Cloudiness and Particulate Formation

Visual inspection of a reconstituted peptide solution is a fundamental preliminary quality check in any laboratory workflow. A fully solubilized CJC-1295 (No DAC) sample should yield a clear, colorless liquid free from visible particulates, haziness, or floating filaments.

Cloudiness or opalescence immediately following reconstitution generally indicates one of three physiological issues:

**Incomplete Dissolution:** The lyophilized cake has not fully solvated into individual peptide monomers, leaving microscopic suspended cake fragments.

**Concentration Saturation:** The volume of diluent added was insufficient for the mass of peptide, exceeding the maximum cjc-1295 (no dac) solubility limit under ambient conditions.

**Structural Aggregation:** Exposure to excessive heat, rapid agitation, or extreme pH shifts has caused the peptide chains to misfold and form beta-sheet-rich insoluble aggregates.

If persistent cloudiness remains after proper recovery steps, the experiment's quantitative accuracy may be compromised due to reduced effective monomer concentration in the supernatant.

Recovery Protocols for Slow-Dissolving Vials Without Mechanical Shearing

When encountering a slow-dissolving lyophilized cake or slight turbidity upon initial fluid contact, researchers must strictly avoid vigorous mechanical shaking. High-shear force (such as vortexing or violent shaking) introduces air bubbles, creates liquid-gas interfaces, and accelerates structural denaturation.

To recover a slow-dissolving CJC-1295 (No DAC) solution safely, follow these standard laboratory handling protocols:

1. **Gentle Axial Swirling:** Hold the vial at a 45-degree angle and gently roll it between your palms or swirl it in a slow circular motion. Allow the solvent to wash gently over the inner glass walls.

2. **Thermal Equilibration:** Allow the vial to stand at room temperature (20°C to 22°C) for 10–15 minutes. Cold diluent directly from refrigeration increases fluid viscosity and slows thermodynamic dissolution.

3. **Passive Incubation:** If minor persistent cloudiness remains, place the vial in a dark cabinet at room temperature for up to 30 minutes. Most high-purity peptides will complete solvation via passive diffusion.

4. **Low-Frequency Sonication:** In rare cases involving high-concentration stocks, placing the sealed vial in a low-frequency ultrasonic water bath for 30–60 seconds at room temperature can disrupt weak intermolecular interactions without shearing the peptide backbone.

Storage Conditions and Solubilized Peptide Degradation Pathways

Proper storage is essential to prevent degradation once CJC-1295 (No DAC) is in solution. Chemical degradation pathways for GHRH analogs in aqueous media primary include deamidation (particularly at asparagine residues), methionine oxidation, and peptide bond hydrolysis.

Lyophilized vials should be stored at -20°C or -80°C for long-term stability. Once reconstituted with bacteriostatic water, stock solutions should be stored at 2°C to 8°C and protected from light. Under these conditions, solution stability is typically maintained for up to 28 days.

Avoid repeated freeze-thaw cycles of reconstituted liquid stocks. Freezing liquid peptide solutions causes ice crystal formation that concentrates the solute into microscopic pockets, drastically altering pH and encouraging aggregation upon thawing. If long-term storage of reconstituted material is necessary, aliquot the stock into single-use polypropylene tubes and freeze once at -80°C.

Comparative Solubility Profiles Across GHRH and GH Secretagogue Classes

When evaluating GHRH analogs and growth hormone secretagogues (GHS) for comparative in vitro studies, researchers should note distinct physical differences in solubility, molecular weight, and half-life characteristics across compounds in this class.

For instance, CJC-1295 with DAC includes a Drug Affinity Complex (DAC) reactive group attached to the Lys27 residue, increasing molecular weight and altering hydrophobic interactions compared to CJC-1295 (No DAC). While CJC-1295 (No DAC) dissolves readily in plain bacteriostatic water at 2 mg/mL, the DAC-bound variant may require slightly longer hydration times due to its larger hydrophobic complex.

Similarly, Sermorelin—the native 29-amino acid sequence of GHRH—exhibits similar solubility characteristics to CJC-1295 (No DAC), but lacks the four amino acid substitutions that grant metabolic resistance. On the secretagogue side, ghrelin receptor agonists like Ipamorelin possess a compact pentapeptide structure that demonstrates rapid solubility in aqueous buffers across a broader pH range. Researchers investigating secretagogue pathways can explore detailed comparative literature in our comprehensive peptide research library.

Quality Verification, HPLC Profiling, and Endotoxin Control at PX1 Research

Solubility consistency depends fundamentally on raw material purity and synthesis quality. Residual trifluoroacetic acid (TFA) salts, organic solvents, or synthesis byproducts left over from manufacturing can alter solution pH and severely impair cjc-1295 (no dac) solubility.

At PX1 Research, every batch of CJC-1295 (No DAC) undergoes rigorous analytical verification in our ISO 17025 accredited testing facilities. We utilize High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to verify structural identity and guarantee a purity threshold exceeding 99.0%.

Additionally, all lots undergo chromogenic LAL testing to verify endotoxin levels fall strictly below standard research safety thresholds (<0.05 EU/mg). Researchers can verify batch-specific analytical data, mass spectrum outputs, and purity chromatograms directly by accessing our public lot-specific COA database prior to ordering. Institutional procurement teams requiring high-volume ordering or customized batch testing are encouraged to establish bulk research accounts for specialized logistics support.